Mon, September 16, 2024
AUS Edition NZ Edition UK Edition CA Edition USA Edition FRA Edition GER Edition ESP Edition ITA Edition NLD Edition
PRT Edition SWE Edition GRC Edition IND Edition POL Edition BRA Edition ZAF Edition RUS Edition CHN Edition UAE Edition
Kalkine Media ASX Share Market News & Research
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. RHT
Healthcare
Facebook Twitter Linkedin

Resonance Health Ltd (ASX:RHT)

0.062 AUD

-0.003 4.615%
Last Updated at: 2024-09-13T00:57:00Z

Resonance Health Ltd

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also provides quantitative imaging measurements and CRO services, such as quality-assured image analysis, project and data management, and issue resolution services; biomarkers, genomics, and laboratory analysis services, as well as works with third party pathology laboratories for blood/sample collection and for standard biochemical/lab safety assessments; design and protocol development, and project management and monitoring services; assessment of subject inclusion or exclusion, evaluating the safety profile of a new therapy, and supporting primary and secondary end-points demonstrating drug efficacy services; and phantoms for the MRI machines. The company serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

141 Burswood Road, Burswood, WA, Australia, 6100

61 8 9286 5300

https://www.resonancehealth.com

Key Executives

Sr. No. Name Title Year Born
1. Mr. Mitchell M. Wells B.Com., B.Comm, L.L.B., LLB MD, Joint Company Sec. & Exec. Director 1975
2. Mr. Nicholas Allan A.C.A., B.Com. CFO, COO & Joint Company Sec. NA
3. Mr. Ben Winters Chief Technology Officer NA
4. Ms. Liesl Ellies Gen. Counsel & Joint Company Sec. NA
5. Mr. Chad Tondut Communications Mang. and GM of Products & Portfolio NA
6. Mr. Ajay Nair Gen. Mang. of Global Sales & Marketing NA
7. Dr. John Olynyk BMedSc, FRACP, M.D., MBBS Chief Medical Officer NA
8. Dr. Timothy Guy St. Pierre B.Sc(Hons), Ph.D. Chief Research Scientist NA
9. Dr. Wenjie Pang Ph.D. Chief Scientific Officer ? Imaging & AI NA
10. Dr. Sherif Boulos Ph.D. Chief Scientific Officer of Molecular NA

Peers

Sector: Healthcare

Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE(x) Forward PE(x) Price Sales TTM(x) Price to Book Value(x) Enterprise Value to Revenue(x) Enterprise Value to EBITDA(x)
PME

Pro Medicus Ltd

 +2.270 1.381% 165.29 196.070 113.636 78.978 70.500 78.095 106.709
ONE

Oneview Healthcare PLC

 0.000 0.000% 0.34 0.000 0.000 24.767 27.118 14.026 -3.525
MDR

Medadvisor Ltd

 -0.050 12.500% 0.35 0.000 25.974 1.580 3.741 1.556 26.955
CGS

CogState Ltd

 0.000 0.000% 0.97 19.400 21.978 3.815 2.639 1.809 7.941

Income Statement

(Currency in AUD)
Breakdown 30-06-2023 30-06-2022 30-06-2021 30-06-2020 30-06-2019
Income Before Tax -1.264M -1.552M 0.344M -0.953M 0.942M
Minority Interest - - - - -
Net Income -0.78M -1.142M 0.586M -0.715M 1.27M
Selling General Administrative 3.136M 2.5M 2.004M 3.571M 1.671M
Gross Profit 4.404M 3.828M 3.779M 3.668M 3.625M
Reconciled Depreciation 0.436M 0.429M 0.364M 0.341M 0.245M
Ebit -1.593M -1.772M 0.188M -1.18M 0.867M
Ebitda -1.157M -1.343M 0.552M -0.839M 1.112M
Depreciation And Amortization 0.436M 0.429M 0.364M 0.341M 0.245M
Operating Income -1.593M -1.772M 0.188M -1.18M 0.867M
Other Operating Expenses 6.029M 5.6M 3.591M 4.848M 2.757M
Interest Expense - 0.003M 0.155M 0.227M 0.075M
Tax Provision -0.484M -0.41M -0.242M -0.238M -0.329M
Interest Income 0.285M 0.003M 0.088M 0.004M 0.037M
Net Interest Income 0.04M 0.003M 0.037M 0.041M 0.037M
Income Tax Expense -0.484M -0.41M -0.242M -0.238M -0.329M
Total Revenue 4.404M 3.828M 3.779M 3.668M 3.625M
Total Operating Expenses 6.029M 5.6M 3.591M 4.848M 2.757M
Cost Of Revenue - - - - -
Total Other Income Expense Net 0.321M 0.221M 0.155M 0.227M 0.075M
Net Income From Continuing Ops -0.78M -1.142M 0.586M -0.715M 1.27M
Net Income Applicable To Common Shares -0.78M -1.142M 0.586M -0.715M 1.27M

Balance Sheet

(Currency in AUD)
Breakdown 30-06-2024 30-06-2023 30-06-2022 30-06-2021 30-06-2020
Total Assets 20.283M 10.983M 11.687M 12.439M 10.497M
Intangible Assets - 2.713M 2.865M 2.595M 2.532M
Other Current Assets 0.11M - 0.06M 0.043M 0.04M
Total Liab 9.351M 1.048M 0.996M 0.612M 0.591M
Total Stockholder Equity 10.932M 9.935M 10.691M 11.827M 9.906M
Other Current Liab 5.342M 0.011M 0.464M 0.401M 0.407M
Common Stock 74.167M 73.883M 73.883M 73.883M 72.565M
Capital Stock - 73.883M 73.883M 73.883M 72.565M
Retained Earnings -65.872M -66.042M -65.261M -64.12M -64.705M
Good Will 7.258M - - - -
Other Assets - 2.796M 2.948M 2.641M 2.578M
Cash 3.404M 6.362M 6.783M 8.857M 6.974M
Cash And Equivalents - 1.037M 6.783M 6.089M 6.974M
Total Current Liabilities 6.147M 0.875M 0.807M 0.612M 0.531M
Current Deferred Revenue 0.011M 0.618M 0.022M 0.032M 0.014M
Net Debt 0.292M -6.089M -6.515M -8.797M -6.858M
Short Term Debt 0.492M 0.1M 0.08M 0.06M 0.056M
Short Long Term Debt - - - - -
Short Long Term Debt Total 3.696M 0.273M 0.268M 0.06M 0.116M
Other Stockholder Equity - -0.271M 2.07M 2.064M 2.046M
Property Plant Equipment - 0.63M 0.391M 0.108M 0.139M
Total Current Assets 9.285M 7.557M 8.348M 9.69M 7.78M
Long Term Investments - 0.083M 0.083M 0.046M 0.046M
Short Term Investments 3.45M - - - -
Net Receivables 2.32M 1.144M 1.505M 0.79M 0.766M
Long Term Debt - - - - -
Inventory - - - - -
Accounts Payable 0.302M 0.145M 0.241M 0.118M 0.054M
Accumulated Other Comprehensive Income 2.637M 2.094M 2.07M 2.064M 2.046M
Non Currrent Assets Other 2.725M 0.083M 0.083M 0.046M 0.046M
Non Current Assets Total 10.998M 3.426M 3.339M 2.749M 2.717M
Capital Lease Obligations - 0.273M 0.268M 0.06M 0.116M
Long Term Debt Total - 0.173M 0.188M 0M 0.06M

Cash Flow

(Currency in AUD)
Breakdown 30-06-2024 30-06-2023 30-06-2022 30-06-2021 30-06-2020
Investments - -0.468M -0.704M -0.396M -0.251M
Total Cashflows From Investing Activities - -0.468M -0.704M -0.396M -0.251M
Total Cash From Financing Activities 3.009M -0.082M -0.107M 1.198M 2.825M
Net Income 0.169M -0.78M -1.142M 0.586M -0.715M
Change In Cash -1.92M -0.422M -2.074M 1.883M 3.893M
Begin Period Cash Flow 5.325M 6.783M 8.857M 6.974M 3.081M
End Period Cash Flow 3.404M 6.362M 6.783M 8.857M 6.974M
Total Cash From Operating Activities 1.387M -0.157M -0.713M 1.169M 1.311M
Depreciation 0.498M 0.436M 0.429M 0.364M 0.341M
Other Cashflows From Investing Activities - - - - -
Dividends Paid - - - - -
Change To Inventory - - - - -
Sale Purchase Of Stock - - 0M 1.25M -0.015M
Other Cashflows From Financing Activities -0.036M -0.082M -0.107M -0.052M -0.052M
Capital Expenditures 0.377M 0.468M 0.704M 0.396M 0.251M
Change In Working Capital -0.088M 0.416M -0.555M 0.049M -0.151M
Other Non Cash Items 1.923M -0.229M 0.555M 0.17M 1.836M
Free Cash Flow 1.01M -0.625M -1.417M 0.773M 1.06M

No data found

Disclaimer

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Related Articles

Code Price Chg %Chg
View All
Code Price Chg %Chg
View All
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Open in the App